Used primarily as an intermediate in the synthesis of pharmaceuticals, particularly in the development of nicotinic acetylcholine receptor modulators. It serves as a key building block in the production of drugs targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structure allows for selective interaction with neural receptors, enhancing cognitive function and providing neuroprotective effects. Also explored in the design of novel antidepressants and anxiolytics due to its ability to cross the blood-brain barrier efficiently. Additionally, it has been investigated for use in smoking cessation therapies owing to its activity on nicotinic pathways.